- Home
- OBIO vs BLNK Comparison
OBIO vs BLNK Comparison
Compare OBIO & BLNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OBIO | BLNK |
|---|---|---|
| Founded | 2017 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Industrial Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 237.2M | 89.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | OBIO | BLNK |
|---|---|---|
| Price | $4.07 | $0.89 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 7 |
| Target Price | ★ $14.25 | $2.13 |
| AVG Volume (30 Days) | 185.5K | ★ 4.3M |
| Earning Date | 11-10-2025 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,818,000.00 | ★ $106,631,000.00 |
| Revenue This Year | $35.75 | N/A |
| Revenue Next Year | $3.07 | $17.87 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 6.46 | N/A |
| 52 Week Low | $2.20 | $0.63 |
| 52 Week High | $6.16 | $2.65 |
Technical Indicators
Market Signals| Indicator | OBIO | BLNK |
|---|---|---|
| Relative Strength Index (RSI) | 42.80 | 50.28 |
| Support Level | $3.92 | $0.82 |
| Resistance Level | $4.53 | $0.92 |
| Average True Range (ATR) | 0.31 | 0.07 |
| MACD | -0.05 | 0.03 |
| Stochastic Oscillator | 14.88 | 67.37 |
Price Performance
Historical ComparisonAbout OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About BLNK Blink Charging Co.
Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The company's business is the sale and distribution of electric vehicle charging equipment and its associated revenues earned from customers and/or Property Partners who use equipment connected to its network. It earns a majority of revenue from U.S.A.